Unchanged levels of interleukins, neopterin, interferon-gamma and tumor necrosis factor-alpha in cerebrospinal fluid of patients with dementia of theAlzheimer type
S. Engelborghs et al., Unchanged levels of interleukins, neopterin, interferon-gamma and tumor necrosis factor-alpha in cerebrospinal fluid of patients with dementia of theAlzheimer type, NEUROCHEM I, 34(6), 1999, pp. 523-530
Several histopathological studies suggest that amyloidogenesis in dementia
of the Alzheimer type is accompanied by activated glia and glia-derived cyt
okines, leading to chronic, self-propagating, cytokine-mediated molecular a
nd cellular reactions. As studies regarding inflammatory changes in cerebro
spinal fluid of patients with dementia of the Alzheimer type has been incon
clusive, we set up a prospective study to assess cerebrospinal fluid levels
of interleukin-1 beta, interleukin-6, interleukin-10, interleukin-12, solu
ble interleukin-2 receptor, interferon-gamma, tumor necrosis factor-alpha a
nd neopterin in 20 patients with dementia of the Alzheimer type and 20 age-
and sex-matched controls. Comparing both groups, no significant difference
s in concentrations and specific activities could be revealed. An additiona
l 22 patients were included to enlarge the study population. No statistical
ly significant differences were shown comparing patients (n=42) with the co
ntrol group (n=20). We conclude that the immune-mediated inflammatory chang
es found in histopathological studies are not reflected in cerebrospinal fl
uid of patients with dementia of the Alzheimer type. Probably, cytokine pro
duction appears very localized in the central nervous system, not allowing
representative detection in cerebrospinal fluid.
Further studies assessing cytokine levels in various regions of central ner
vous system of patients with dementia of the Alzheimer type will be of inte
rest to confirm this hypothesis. (C) 1999 Elsevier Science Ltd. All rights
reserved.